000144819 001__ 144819
000144819 005__ 20240826163725.0
000144819 0247_ $$2doi$$a10.53846/goediss-5944
000144819 037__ $$aDZNE-2020-00261
000144819 041__ $$aEnglish
000144819 1001_ $$0P:(DE-2719)2811738$$aStündl, Anne-Katrin$$b0$$eFirst author$$udzne
000144819 245__ $$aCharacterization of exosomes as a diagnostic marker in neurodegenerative diseases$$f - 2016-08-16
000144819 260__ $$c2016
000144819 300__ $$a95 pages : illustrations, XII
000144819 3367_ $$2DataCite$$aOutput Types/Dissertation
000144819 3367_ $$2ORCID$$aDISSERTATION
000144819 3367_ $$2BibTeX$$aPHDTHESIS
000144819 3367_ $$02$$2EndNote$$aThesis
000144819 3367_ $$0PUB:(DE-HGF)11$$2PUB:(DE-HGF)$$aDissertation / PhD Thesis$$bphd$$mphd$$s1724680275_22476
000144819 3367_ $$2DRIVER$$adoctoralThesis
000144819 502__ $$aDissertation, Georg-August-Universität zu Göttingen, 2016$$bDissertation$$cGeorg-August-Universität zu Göttingen$$d2016$$o2016-08-16
000144819 520__ $$aα-Synuclein pathology has been hypothesized to propagate in synucleinopathies by intercellular transfer of pathogenic seeds in a prion-like fashion. Extracellular release of α-Synuclein via small extracellular vesicles has been proposed as one of the mechanisms of cell-to-cell disease transmission. In vitro, extracellular α-Synuclein has been detected in exosomal vesicles and we have recently provided evidence that α-Synuclein is present in exosomes in the central nervous system in vivo. We hypothesized that exosomes from patients with α Synuclein related neurodegeneration serve as carriers for interneuronal disease transfer. In this study, we purified exosomes from cerebrospinal fluid from patients with synucleinopathies including Parkinson`s disease and dementia with Lewy bodies, progressive supranuclear palsy as an example of a disease that clinically overlaps with Parkinson`s disease but without underlying α-Synuclein pathology and other neurological controls without neurodegenerative diseases. Exosome numbers and exosomal α-Synuclein levels were quantified and their potential to induce aggregation of soluble α-Synuclein was evaluated. We observed differences in cerebrospinal fluid exosomal α-Synuclein levels between patients with Parkinson`s disease and dementia with Lewy bodies and between dementia with Lewy bodies and controls. In addition, exosomal α-Synuclein levels correlated with cognitive decline and Tau levels as a marker of neurodegeneration in dementia with Lewy bodies. By analyzing exosomal α-Synuclein levels and exosome numbers, we were able to distinguish Parkinson`s disease from dementia with Lewy bodies and controls as well as dementia with Lewy bodies from Parkinson`s disease and controls with high sensitivity and specificity. Importantly, cerebrospinal fluid exosomes from Parkinson`s disease and dementia with Lewy bodies disease patients induced aggregation of α-Synuclein in a reporter cell model, dependent on the amount of exosomal α-Synuclein. Thus, exosomal α-Synuclein could serve as a diagnostic biomarker for α-Synuclein related neurodegenerative diseases and as a progression marker in dementia with Lewy bodies. These findings further indicate that cerebrospinal fluid derived exosomes from patients with Parkinson`s disease and dementia with Lewy bodies contain a pathogenic α-Synuclein species, which induces aggregation of endogenous α-Synuclein in recipient neurons and therefore could transmit disease pathology. Since multiple recent therapy trials in Alzheimer`s disease have failed and therapeutic interventions are most promising in early and even preclinical stages, the accurate identification of patients with Alzheimer`s disease is indispensable. Therefore, diagnostic and prognostic biomarkers are required and identification of such markers would also give insight into the underlying molecular mechanisms of Alzheimer`s disease pathology. Accumulating evidence suggests that dysregulation of processes, which physiologically regulate gene expression, plays an important role in the pathogenesis of neurodegenerative diseases. Additionally, dysregulation of small non-coding RNAs in Alzheimer`s disease brain has been shown in various studies. In our second study, we analyzed the small non-coding RNA composition of exosomes derived from human cerebrospinal fluid in order to test whether exosomal small non-coding RNA profiles can be used as a disease signature for Alzheimer`s disease. Here, we show that genome-wide profiling of cerebrospinal fluid exosomal small non-coding RNA expression reveals a specific small RNA signature which differentiates Alzheimer`s disease from cognitive healthy controls. Thus, our selected set of exosomal small non-coding RNAs could be used as a potential biomarker in the future, replication in a larger validation cohort provided.
000144819 536__ $$0G:(DE-HGF)POF3-344$$a344 - Clinical and Health Care Research (POF3-344)$$cPOF3-344$$fPOF III$$x0
000144819 588__ $$aDataset connected to DataCite
000144819 773__ $$a10.53846/goediss-5944
000144819 8564_ $$uhttps://ediss.uni-goettingen.de/handle/11858/00-1735-0000-002B-7C51-B
000144819 8564_ $$uhttps://pub.dzne.de/record/144819/files/DZNE-2020-00261.pdf$$yOpenAccess
000144819 8564_ $$uhttps://pub.dzne.de/record/144819/files/DZNE-2020-00261.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000144819 909CO $$ooai:pub.dzne.de:144819$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000144819 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811738$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000144819 9131_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x0
000144819 9141_ $$y2016
000144819 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000144819 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
000144819 920__ $$lyes
000144819 9201_ $$0I:(DE-2719)1440011$$kAG Schneider Göttingen$$lTranslational Dementia Research Göttingen$$x0
000144819 980__ $$aphd
000144819 980__ $$aVDB
000144819 980__ $$aI:(DE-2719)1440011
000144819 980__ $$aUNRESTRICTED
000144819 9801_ $$aFullTexts